|
1.
INVESTMENT HIGHLIGHTS File Format: PDF/Adobe Acrobat - View as HTML provides for 7 and 10 years of post-approval market exclusivity, respectively. In the US, orBec. ® has also been granted orphan drug designation for the ... 2.
DOR BioPharma, Inc. Home Pharmaceutical company focused on developing oral and mucosal delivery of injectable drugs and vaccines. Features company profile, products, ... 3.
DOR BioPharma, Inc. Home Pharmaceutical company focused on developing oral and mucosal delivery of injectable drugs and vaccines. Features company profile, products, ... 4.
DOR BioPharma, Inc. Home Pharmaceutical company focused on developing oral and mucosal delivery of injectable drugs and vaccines. Features company profile, products, ... 5.
Draft Script of Conference Call File Format: PDF/Adobe Acrobat - View as HTML Our next question or comment comes from Jeffrey Benison. ... Jeffrey Benison: And I was going to go here and read through a load of your ... 6.
INVESTMENT HIGHLIGHTS File Format: PDF/Adobe Acrobat - View as HTML of the GI tract such as chronic GVHD, radiation enteritis, radiation injury and ... reducing the need for systemic immunosuppressive drugs to treat GI GVHD. ... 7.
DOR BioPharma, Inc. Home Pharmaceutical company focused on developing oral and mucosal delivery of injectable drugs and vaccines. Features company profile, products, ... 8.
DOR BioPharma, Inc. Home Pharmaceutical company focused on developing oral and mucosal delivery of injectable drugs and vaccines. Features company profile, products, ... 9.
DOR BioPharma, Inc. Home Located in Lake Forest, Illinois, DOR BioPharma, Inc. is a pharmaceutical company specializing in the oral and mucosal delivery of drugs and vaccines. ... 10.
DOR BioPharma, Inc. Home DOR BioPharma, Inc. ( DOR ) is a late-stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and ... |
| |
|
View More »
|
